打破“纸上谈兵”，inne在CBME打响儿童营养行业临床实证“第一枪”

Core Viewpoint - The article emphasizes the importance of "clinical validation" as a critical standard for evaluating children's health products, particularly calcium supplements, in the context of evolving scientific parenting concepts [1][6]. Group 1: Industry Trends - The children's nutrition industry is transitioning from "experience-driven" to "evidence-based" approaches, with a focus on clinical validation to establish new standards for calcium supplementation [3][14]. - Over 50% of calcium supplements in the market are still basic forms like calcium carbonate and lactate, with only 15% having undergone clinical trials, indicating a significant gap in scientific validation [4][6]. Group 2: Company Initiatives - Inne, a German-origin children's nutrition brand, has launched a comprehensive clinical validation system and hosted an academic conference titled "Clinical Validation: A Revolutionary Approach to Scientific Calcium Supplementation" [1][3]. - The company has established global research centers in Germany, China, Australia, and the USA, focusing on high-absorption, preservative-free nutritional products [4][11]. Group 3: Clinical Research and Findings - Clinical studies conducted in collaboration with reputable institutions have shown that Inne's proprietary ingredient, Kidtal, significantly promotes growth and bone health in children aged 2-12 [7][8]. - Research published in the international journal "Nutrients" has validated the effectiveness of Kidtal, enhancing its credibility in the scientific community [8][9]. Group 4: Future Directions - Inne plans to continue its commitment to scientific innovation and deepen clinical research collaborations to provide safer, more effective nutritional solutions for children's health [15].